code
stringlengths 3
7
| description
stringlengths 5
2.01k
|
|---|---|
A04.0 | Enteropathogenic Escherichia coli infection |
A04.1 | Enterotoxigenic Escherichia coli infection |
A04.2 | Enteroinvasive Escherichia coli infection |
A04.3 | Enterohemorrhagic Escherichia coli infection |
A04.4 | Other intestinal Escherichia coli infections Inclusion term(s):Escherichia coli enteritis NOS |
A04.5 | Campylobacter enteritis |
A04.6 | Enteritis due to Yersinia enterocolitica |
A04.7 | Enterocolitis due to Clostridium difficile Inclusion term(s):Foodborne intoxication by Clostridium difficilePseudomembraneous colitis |
A04.71 | Enterocolitis due to Clostridium difficile, recurrent |
A04.72 | Enterocolitis due to Clostridium difficile, not specified as recurrent |
A04.8 | Other specified bacterial intestinal infections |
A04.9 | Bacterial intestinal infection, unspecified Inclusion term(s):Bacterial enteritis NOS |
Q10 | Congenital malformations of eyelid, lacrimal apparatus and orbit Excludes1cryptophthalmos NOS (Q11.2)cryptophthalmos syndrome (Q87.0) |
Q10.0 | Congenital ptosis |
Q10.1 | Congenital ectropion |
Q10.2 | Congenital entropion |
Q10.3 | Other congenital malformations of eyelid Inclusion term(s):AblepharonBlepharophimosis, congenitalColoboma of eyelidCongenital absence or agenesis of ciliaCongenital absence or agenesis of eyelidCongenital accessory eyelidCongenital accessory eye muscleCongenital malformation of eyelid NOS |
Q10.4 | Absence and agenesis of lacrimal apparatus Inclusion term(s):Congenital absence of punctum lacrimale |
Q10.5 | Congenital stenosis and stricture of lacrimal duct |
Q10.6 | Other congenital malformations of lacrimal apparatus Inclusion term(s):Congenital malformation of lacrimal apparatus NOS |
Q10.7 | Congenital malformation of orbit |
Z3A | Weeks of gestation Note: Codes from category Z3A are for use, only on the maternal record, to indicate the weeks of gestation of the pregnancy, if known. |
Z3A.0 | Weeks of gestation of pregnancy, unspecified or less than 10 weeks |
Z3A.00 | Weeks of gestation of pregnancy not specified |
Z3A.01 | Less than 8 weeks gestation of pregnancy |
Z3A.08 | 8 weeks gestation of pregnancy |
Z3A.09 | 9 weeks gestation of pregnancy |
Z3A.1 | Weeks of gestation of pregnancy, weeks 10-19 |
Z3A.10 | 10 weeks gestation of pregnancy |
Z3A.11 | 11 weeks gestation of pregnancy |
Z3A.12 | 12 weeks gestation of pregnancy |
Z3A.13 | 13 weeks gestation of pregnancy |
Z3A.14 | 14 weeks gestation of pregnancy |
Z3A.15 | 15 weeks gestation of pregnancy |
Z3A.16 | 16 weeks gestation of pregnancy |
Z3A.17 | 17 weeks gestation of pregnancy |
Z3A.18 | 18 weeks gestation of pregnancy |
Z3A.19 | 19 weeks gestation of pregnancy |
Z3A.2 | Weeks of gestation of pregnancy, weeks 20-29 |
Z3A.20 | 20 weeks gestation of pregnancy |
Z3A.21 | 21 weeks gestation of pregnancy |
Z3A.22 | 22 weeks gestation of pregnancy |
Z3A.23 | 23 weeks gestation of pregnancy |
Z3A.24 | 24 weeks gestation of pregnancy |
Z3A.25 | 25 weeks gestation of pregnancy |
Z3A.26 | 26 weeks gestation of pregnancy |
Z3A.27 | 27 weeks gestation of pregnancy |
Z3A.28 | 28 weeks gestation of pregnancy |
Z3A.29 | 29 weeks gestation of pregnancy |
Z3A.3 | Weeks of gestation of pregnancy, weeks 30-39 |
Z3A.30 | 30 weeks gestation of pregnancy |
Z3A.31 | 31 weeks gestation of pregnancy |
Z3A.32 | 32 weeks gestation of pregnancy |
Z3A.33 | 33 weeks gestation of pregnancy |
Z3A.34 | 34 weeks gestation of pregnancy |
Z3A.35 | 35 weeks gestation of pregnancy |
Z3A.36 | 36 weeks gestation of pregnancy |
Z3A.37 | 37 weeks gestation of pregnancy |
Z3A.38 | 38 weeks gestation of pregnancy |
Z3A.39 | 39 weeks gestation of pregnancy |
Z3A.4 | Weeks of gestation of pregnancy, weeks 40 or greater |
Z3A.40 | 40 weeks gestation of pregnancy |
Z3A.41 | 41 weeks gestation of pregnancy |
Z3A.42 | 42 weeks gestation of pregnancy |
Z3A.49 | Greater than 42 weeks gestation of pregnancy |
Z12 | Encounter for screening for malignant neoplasms Inclusion term(s):Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.Use additional code to identify any family history of malignant neoplasm (Z80.-)Excludes1encounter for diagnostic examination-code to sign or symptom |
Z12.0 | Encounter for screening for malignant neoplasm of stomach |
Z12.1 | Encounter for screening for malignant neoplasm of intestinal tract |
Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
Z12.11 | Encounter for screening for malignant neoplasm of colon Inclusion term(s):Encounter for screening colonoscopy NOS |
Z12.12 | Encounter for screening for malignant neoplasm of rectum |
Z12.13 | Encounter for screening for malignant neoplasm of small intestine |
Z12.2 | Encounter for screening for malignant neoplasm of respiratory organs |
Z12.3 | Encounter for screening for malignant neoplasm of breast |
Z12.31 | Encounter for screening mammogram for malignant neoplasm of breast |
Z12.39 | Encounter for other screening for malignant neoplasm of breast |
Z12.4 | Encounter for screening for malignant neoplasm of cervix Inclusion term(s):Encounter for screening pap smear for malignant neoplasm of cervix |
Z12.5 | Encounter for screening for malignant neoplasm of prostate |
Z12.6 | Encounter for screening for malignant neoplasm of bladder |
Z12.7 | Encounter for screening for malignant neoplasm of other genitourinary organs |
Z12.71 | Encounter for screening for malignant neoplasm of testis |
Z12.72 | Encounter for screening for malignant neoplasm of vagina Inclusion term(s):Vaginal pap smear status-post hysterectomy for non-malignant condition |
Z12.73 | Encounter for screening for malignant neoplasm of ovary |
Z12.79 | Encounter for screening for malignant neoplasm of other genitourinary organs |
Z12.8 | Encounter for screening for malignant neoplasm of other sites |
Z12.81 | Encounter for screening for malignant neoplasm of oral cavity |
Z12.82 | Encounter for screening for malignant neoplasm of nervous system |
Z12.83 | Encounter for screening for malignant neoplasm of skin |
Z12.89 | Encounter for screening for malignant neoplasm of other sites |
Z12.9 | Encounter for screening for malignant neoplasm, site unspecified |
D80 | Immunodeficiency with predominantly antibody defects |
D80.0 | Hereditary hypogammaglobulinemia Inclusion term(s):Autosomal recessive agammaglobulinemia (Swiss type)X-linked agammaglobulinemia [Bruton] (with growth hormone deficiency) |
D80.1 | Nonfamilial hypogammaglobulinemia Inclusion term(s):Agammaglobulinemia with immunoglobulin-bearing B-lymphocytesCommon variable agammaglobulinemia [CVAgamma]Hypogammaglobulinemia NOS |
D80.2 | Selective deficiency of immunoglobulin A [IgA] |
D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses |
D80.4 | Selective deficiency of immunoglobulin M [IgM] |
D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] |
D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
D80.7 | Transient hypogammaglobulinemia of infancy |
D80.8 | Other immunodeficiencies with predominantly antibody defects Inclusion term(s):Kappa light chain deficiency |